查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598470

外用藥物市場：依產品、最終用途分類 - 全球預測 2025-2030

Topical Drugs Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), End-use (Burn Centers, Home Care Settings, Hospitals & Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年外用藥物市場價值為154.4億美元，預計到2024年將達到168.6億美元，複合年成長率為9.64%，到2030年將達到294.3億美元。

外用藥物是直接塗布於皮膚或黏膜特定部位並用於局部治療的製劑。這些藥物對於治療各種皮膚病、緩解疼痛、感染疾病和發炎至關重要，並且提供了副作用減少的全身性藥物的替代方案。應用範圍包括皮膚科、眼科、牙科等，並用於治療和美容目的。最終用途市場包括醫院、診所和居家醫療機構，由於人口老化和皮膚病患病率上升，越來越多的患者更喜歡非侵入性治療。影響市場的主要成長要素包括配方技術的進步，例如奈米技術和生技藥品的使用，以及由於消費者意識的提高而越來越傾向於自我治療。潛在的機會存在於醫療保健支出不斷增加且未滿足的醫療需求不斷增加的區域市場，例如亞太地區和拉丁美洲。鼓勵公司轉向個人化醫療，並利用 3D 列印等創新來客製化並更有效地滿足個別患者的需求。然而，市場面臨一些限制，例如產品核可過程中的監管挑戰以及在不被系統吸收的情況下實現所需功效和穩定性的配方挑戰。以研發成本高昂為特徵的競爭格局給新進者帶來了特殊的挑戰。對於市場相關人員來說，加強藥物傳輸技術、開發多功能製劑以及投資生物基產品的潛力等創新領域提供了良好的前景。對市場格局的洞察表明，市場適度分散，主要參與者不斷尋求透過策略併購來擴大其產品組合。了解消費者趨勢、監管要求以及投資先進交付機制的研發對於這個不斷發展的市場的持續成長和競爭優勢至關重要。

主要市場統計
基準年[2023] 154.4億美元
預測年份 [2024] 168.6億美元
預測年份 [2030] 294.3億美元
複合年成長率（%） 9.64%

市場動態：揭示快速發展的外用藥物市場的關鍵市場洞察

供需的動態交互作用正在改變外用藥物市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 皮膚病和糖尿病盛行率上升
    • 對不含類固醇的自行給藥藥物和外用藥物的需求增加
    • 政府對外用藥物的有利核准
  • 市場限制因素
    • 與局部治療相關的刺激或過敏
  • 市場機會
    • 局部用藥處方的創新
    • 藥物輸送系統的進展
  • 市場挑戰
    • 外用藥物的複雜處方

波特的五力：駕馭局部藥物市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外用藥物市場的外部影響

外部宏觀環境因素在塑造外用藥物市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解外用藥物市場的競爭狀況

外用藥物市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣外用藥物市場供應商績效評估

FPNV定位矩陣是評估外用藥品市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪外用藥物市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，外用藥物市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 皮膚病和糖尿病的發生率增加
      • 對不含類固醇的自行給藥藥物和外用藥物的需求增加
      • 政府對外用藥物的有利核准
    • 抑制因素
      • 與局部治療相關的刺激和過敏
    • 機會
      • 外用藥物配方的創新
      • 藥物輸送系統的進展
    • 任務
      • 外用藥物的複雜配方
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 外用藥物市場：依產品

  • 液體配方
    • 解決方案
    • 暫停
  • 半固態製劑
    • 奶油
    • 凝膠
    • 洗劑
    • 軟膏
    • 貼上
  • 固態製劑
    • 粉末
    • 栓劑
  • 經皮吸收產品
    • 經皮吸收貼片
    • 經皮固態藥物

第7章 外用藥物市場：依最終用途分類

  • 燒燙傷中心
  • 家庭護理設置
  • 醫院/診所

第8章 北美和南美外用藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太外用藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲外用藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Almirall, SA
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cigna Health and Life Insurance Company
  • Concert Pharmaceuticals
  • Eli Lilly and Company
  • GlaxoSmithkline PLC
  • Hisamitsu Pharmaceuticals Co. Inc.
  • Johnson & Johnson Services, Inc.
  • LEO Pharma A/S
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Mylan NV
  • Tergus Pharma
Product Code: MRR-F927BA46264B

The Topical Drugs Market was valued at USD 15.44 billion in 2023, expected to reach USD 16.86 billion in 2024, and is projected to grow at a CAGR of 9.64%, to USD 29.43 billion by 2030.

Topical drugs are formulations applied directly to a specific area of the skin or mucous membranes, aimed at providing localized treatment. These drugs are essential in managing various skin conditions, pain relief, infections, and inflammation, offering an alternative to systemic medications with reduced side effects. The application scope encompasses dermatological, ophthalmic, dental, alongside others, serving both therapeutic and cosmetic purposes. With an expanding aging population and increasing prevalence of skin diseases, the end-use market includes hospitals, clinics, and home-care settings, driven by a patient preference for non-invasive treatments. Key growth factors influencing the market include technological advancements in formulation techniques like the use of nanotechnology and biologics, and an increasing inclination towards self-medication practices boosted by heightened consumer awareness. Potential opportunities lie in geographic markets with rising healthcare expenditures and unmet medical needs, such as in Asia-Pacific and Latin America. Companies are advised to pivot towards personalized medicine and leverage innovations like 3D printing for customization, addressing individual patient needs more effectively. However, the market faces limitations, such as the regulatory challenges of product approval processes, and formulation difficulties in achieving the desired efficacy and stability without systemic absorption. The competitive landscape, characterized by intense R&D costs, particularly poses a challenge for new entrants. For market players, innovation areas such as enhancing drug delivery technologies, developing multi-functional formulations, and investing in the potential of bio-based products present lucrative prospects. Insights into the nature of the market suggest a moderately fragmented landscape, with key players constantly attempting to broaden their portfolios through strategic mergers and acquisitions. Understanding consumer trends, regulatory requirements, and investing in R&D for advanced delivery mechanisms will be crucial for sustained growth and a competitive edge in this evolving market.

KEY MARKET STATISTICS
Base Year [2023] USD 15.44 billion
Estimated Year [2024] USD 16.86 billion
Forecast Year [2030] USD 29.43 billion
CAGR (%) 9.64%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Topical Drugs Market

The Topical Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of skin disorders, and diabetes
    • Increasing demand for self-administered drugs and steroid-free topical medication
    • Favorable government approvals for topical drugs
  • Market Restraints
    • Irritations and allergies associated with topical treatments
  • Market Opportunities
    • Innovation in topical drug formulations
    • Advancements in drug delivery systems
  • Market Challenges
    • Complex formulations of topical drugs

Porter's Five Forces: A Strategic Tool for Navigating the Topical Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Topical Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Topical Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Topical Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Topical Drugs Market

A detailed market share analysis in the Topical Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Topical Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Topical Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Topical Drugs Market

A strategic analysis of the Topical Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Topical Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Almirall, S.A, Bausch Health Companies Inc., Bayer AG, Cigna Health and Life Insurance Company, Concert Pharmaceuticals, Eli Lilly and Company, GlaxoSmithkline PLC, Hisamitsu Pharmaceuticals Co. Inc., Johnson & Johnson Services, Inc., LEO Pharma A/S, Lupin Limited, Mayne Pharma Group Limited, Mylan N.V., and Tergus Pharma.

Market Segmentation & Coverage

This research report categorizes the Topical Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Liquid Formulations, Semi-Solid Formulations, Solid Formulations, and Transdermal Products. The Liquid Formulations is further studied across Solutions and Suspensions. The Semi-Solid Formulations is further studied across Creams, Gel, Lotions, Ointments, and Pastes. The Solid Formulations is further studied across Powders and Suppositories. The Transdermal Products is further studied across Transdermal Patches and Transdermal Semi-Solids.
  • Based on End-use, market is studied across Burn Centers, Home Care Settings, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of skin disorders, and diabetes
      • 5.1.1.2. Increasing demand for self-administered drugs and steroid-free topical medication
      • 5.1.1.3. Favorable government approvals for topical drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Irritations and allergies associated with topical treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovation in topical drug formulations
      • 5.1.3.2. Advancements in drug delivery systems
    • 5.1.4. Challenges
      • 5.1.4.1. Complex formulations of topical drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Topical Drugs Market, by Product

  • 6.1. Introduction
  • 6.2. Liquid Formulations
    • 6.2.1. Solutions
    • 6.2.2. Suspensions
  • 6.3. Semi-Solid Formulations
    • 6.3.1. Creams
    • 6.3.2. Gel
    • 6.3.3. Lotions
    • 6.3.4. Ointments
    • 6.3.5. Pastes
  • 6.4. Solid Formulations
    • 6.4.1. Powders
    • 6.4.2. Suppositories
  • 6.5. Transdermal Products
    • 6.5.1. Transdermal Patches
    • 6.5.2. Transdermal Semi-Solids

7. Topical Drugs Market, by End-use

  • 7.1. Introduction
  • 7.2. Burn Centers
  • 7.3. Home Care Settings
  • 7.4. Hospitals & Clinics

8. Americas Topical Drugs Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Topical Drugs Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Topical Drugs Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Almirall, S.A
  • 3. Bausch Health Companies Inc.
  • 4. Bayer AG
  • 5. Cigna Health and Life Insurance Company
  • 6. Concert Pharmaceuticals
  • 7. Eli Lilly and Company
  • 8. GlaxoSmithkline PLC
  • 9. Hisamitsu Pharmaceuticals Co. Inc.
  • 10. Johnson & Johnson Services, Inc.
  • 11. LEO Pharma A/S
  • 12. Lupin Limited
  • 13. Mayne Pharma Group Limited
  • 14. Mylan N.V.
  • 15. Tergus Pharma

LIST OF FIGURES

  • FIGURE 1. TOPICAL DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. TOPICAL DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TOPICAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TOPICAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TOPICAL DRUGS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TOPICAL DRUGS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. TOPICAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. TOPICAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TOPICAL DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TOPICAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TOPICAL DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TOPICAL DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TOPICAL DRUGS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TOPICAL DRUGS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TOPICAL DRUGS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PASTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TOPICAL DRUGS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL SEMI-SOLIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TOPICAL DRUGS MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 281. TOPICAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 282. TOPICAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023